Reports and informative resources provided by the TRO.
To acknowledge 10 years of operation in 2021, weÌýput together a review of our achievements to celebrate all things TRO - from funding successes, drug discoveries and project progressions from preclinical to clinical, to spin out contributions and the development of long-term industry relationships.Ìý We also highlight how our vision and values in the areas of Research, Innovation and Education contribute to wider Â鶹´«Ã½ÊÓƵÍøÕ¾ goals and how we will continue to build on an increasingly vibrant translational culture over the next 10 years. Ìý | |
Jane Kinghorn, Director at Â鶹´«Ã½ÊÓƵÍøÕ¾ Translational Research Office and Nick McNally, Managing Director Research Â鶹´«Ã½ÊÓƵÍøÕ¾/Â鶹´«Ã½ÊÓƵÍøÕ¾H, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.Ìý | |
Jane Kinghorn, Â鶹´«Ã½ÊÓƵÍøÕ¾ TRO DirectorÌýand Anne Lane, CEO at Â鶹´«Ã½ÊÓƵÍøÕ¾ Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at Â鶹´«Ã½ÊÓƵÍøÕ¾ and their partner hospitals. | |
Translational education and training for early career researchersIn this interview, Colby Benari, Head of the Academic Careers Office (ACO) at Â鶹´«Ã½ÊÓƵÍøÕ¾, discusses the role and impact of the Â鶹´«Ã½ÊÓƵÍøÕ¾ ACO and highlights new translational training opportunities for Early Career Researchers.Ìý | |
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office)Ìýat Â鶹´«Ã½ÊÓƵÍøÕ¾, explain the value of drug discovery in academia in bridging the "Valley of Death". | |
The innovation gameProfessor David Lomas discusses the Therapeutic Innovation Networks (TINs), which are facilitating and accelerating enterprise at University College London (Â鶹´«Ã½ÊÓƵÍøÕ¾), | |
Jane Kinghorn, along with Marta Ribeiro, Felipe Fouto, and Colby Benari from Â鶹´«Ã½ÊÓƵÍøÕ¾, argue that the ability to listen and learn makes Â鶹´«Ã½ÊÓƵÍøÕ¾ a global partner of choice for health research and innovation.Ìý | |
Translating novel science to patient benefitDr Jane Kinghorn discusses how University College London (Â鶹´«Ã½ÊÓƵÍøÕ¾)’s Translational Research Office (TRO) is working to encourage, facilitate and contribute to the translation of Â鶹´«Ã½ÊÓƵÍøվ’s and its partner hospitals’ research. | |
Cell, Gene and Regenerative Therapies at Â鶹´«Ã½ÊÓƵÍøÕ¾ and NHS Partner TrustsÂ鶹´«Ã½ÊÓƵÍøÕ¾ in partnership with our three NIHR BRCs at University College London Hospital (Â鶹´«Ã½ÊÓƵÍøÕ¾H), Great Ormond Street Hospital for Children (GOSH) and Moorfields Eye Hospital (MEH) are world leaders in the development and delivery to patients of novel cell, gene and regenerative therapies.Ìý | |
Â鶹´«Ã½ÊÓƵÍøÕ¾ supporting Healthcare Leadership and Innovation capacity building in AfricaIn late 2018, Â鶹´«Ã½ÊÓƵÍøվ’s Academic Careers Office (ACO) and Translational Research Office (TRO) along with Â鶹´«Ã½ÊÓƵÍøÕ¾ partner the Africa Health Research Institute (AHRI), were successful in applying for a UKRI Global Challenge Research Fund Impact Acceleration Award (GCRF IAA).ÌýThe ACO and TRO organised two events in South Africa open to participants from across the African continent. |